Hospitals are key to hepatitis C via micro-elimination

Published in Healthcare & Nursing
Hospitals are key to hepatitis C via micro-elimination

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Eliminating the hepatitis C virus (HCV) is within humanity’s reach. 

Read that again please: Eliminating HCV is within humanity’s reach.

Still reading? Great!

If you’re still reading, it’s highly probable that you're part of a global community of practice focused on viral hepatitis specifically or infectious diseases in general. And if your work involves hospital settings, in particular, it’s crucial that you continue reading.

You might be wondering: how could I or my hospital have a part to play in eliminating HCV? It’s an important question in fact, I can assure you this from drawing on the rapidly growing evidence base.

We have global alignment now, if not consensus, on micro-elimination as an integral part of the going-forward strategy to eliminate HCV. We know where micro-elimination is working. We also know where it’s underutilised (strong hint: hospitals).

What’s micro-elimination? In a nutshell, the strategy consists of breaking down the seemingly daunting, national HCV elimination goals into smaller, more manageable goals which target specific sub-populations or settings. As such, breaking these goals down into more easily achievable targets greatly facilitates the elimination of HCV.

A micro-elimination initiative has four main components and, depending upon your role in public health policy or health systems, you may play a part in one or more of these components:

  1. A clearly defined plan;
  2. Time-bound targets;
  3. A multistakeholder process; and
  4. Monitoring of outcomes.

Why are hospitals key?

If you are involved in hospitals, your role is crucial. Why? Because while hospitals are one of the most obvious settings, serving multiple at-risk populations, HCV is still holding its ground in these very places.

As demonstrated in our article in Communications Medicine, micro-elimination should be considered as a priority in hospitals, given that it leverages the fact that individuals at higher risk of HCV infection are already in care there. Yet, in a review of almost 4,000 hospital patient records, we found that around one in ten high-risk patients in public hospitals in Madrid, Spain, had not been tested for HCV, in spite of direct-acting antiviral therapy being universally available in the country since 2017 and HCV elimination being a strategic goal of the Spanish government.

While the data derived from Madrid are deemed promising, it's not clear what the situation looks like in other cities across Spain or beyond. What is getting clearer every day is that HCV testing among hospitalised patients is a critical intervention for HCV elimination. If you think your hospital might have cases of HCV, please advocate for immediate adoption or expansion of HCV testing now!

What specific actions should hospitals take within health systems?

Health systems need to ensure that everyone receiving care, and who are at heightened risk of HCV, be they on haemodialysis or co-infected with HIV, is offered a test for HCV. Micro-elimination in hospitals provides a unique and effective path towards HCV elimination as a public health threat by the end of this decade – and in Spain much sooner, with your engagement. To facilitate the process, every hospital should, at a minimum, follow the four steps set out in Table 1. This will ensure that all high-risk populations in hospital care are tested for HCV and that this testing is efficiently carried out.

Table 1. Hepatitis C virus (HCV) elimination checklist in hospital settings

1. Screen for HCV in all high-risk populations:

·       patients in haemodialysis or pre-dialysis programmes;

·       co-infected with HIV;

·       with advanced liver disease;

·       with hereditary haematological diseases;

·       with transplants; and

·       people who inject drugs (including in addiction centres affiliated with hospitals).

2. Reach those who have been lost to follow-up, including individuals who may have been diagnosed before direct-acting antiviral therapy became widely available.

3. Ensure reflex testing in the laboratory for all patients that test HCV antibody positive.

4. Employ microbiology alerts to expedite the time between diagnosis and treatment prescription for all diagnosed HCV patients.

Do other settings have a role? They do, just not quite like hospitals.

Outside of hospitals, there have also been successful micro-elimination efforts in Spain, including the first prison in the world to eliminate HCV, initiatives in harm reduction centres, HCV elimination via a mobile unit and an ongoing effort in an entire region – inspired by the success in Tayside, Scotland.

Let’s recall the infamous words of Willie Sutton: When asked why he robbed banks, Sutton simply replied, “Because that's where the money is.” 

Why is testing in hospitals so crucial for HCV micro-elimination? Because that’s where so many of the high-risk patients are.

The time to act (& test) is now!

Let’s read our bold statement one more time:  

Eliminating HCV is within humanity’s reach.

What are we waiting for? And, specifically, what are you waiting for?

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Health Care
Life Sciences > Health Sciences > Health Care

Related Collections

With collections, you can get published faster and increase your visibility.

Advances in MASLD/NAFLD

This Collection welcomes clinical, translational, epidemiological, and public health research focused on MASLD/NAFLD.

Publishing Model: Open Access

Deadline: Jun 30, 2024

Liquid biopsy

This Collection welcomes clinical and translational research on liquid biopsy approaches in cancer.

Publishing Model: Open Access

Deadline: Aug 13, 2024